WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Earnings & Revenue

CRSP past revenue growth

How has CRSP's revenue growth performed historically?
Company
30,885.48%
Industry
169.3%
Market
17.86%
CRSP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CRSP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CRSP's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CRSP earnings and revenue history

Current Revenue
$371.2M
Current Earnings
-$153.6M
Current Profit Margin
-41.4%

CRSP Return on Equity

Current Company
-8.4%
Current Industry
-63.4%
Current Market
188%
CRSP's Return on Equity (-8.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CRSP announces earnings.

CRSP Return on Assets

Current Company
-7%
Current Industry
3.2%
CRSP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CRSP Return on Capital Employed

Current Company
-7.11%
Current Industry
19.9%
CRSP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRSP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CRSP$371.21M-$130.89M-$153.61M+160.00%N/A
BPMC$249.38M-$466.45M-$506.98M+41.14%N/A
BBIO$9.30M-$551.39M-$643.20M-30.80%N/A
RVMD$11.58M-$430.28M-$436.37M-10.50%N/A
HALO$829.25M$451.95M$281.59M+40.43%+107.49%

CRSP earnings dates

Next earnings date
May 6, 2024

Crispr Therapeutics Ag Earnings & Revenue FAQ

What were CRSP's earnings last quarter?

On Invalid Date, Crispr Therapeutics Ag (NASDAQ: CRSP) reported Q4 2023 earnings per share (EPS) of $1.13, up 180.71% year over year. Total Crispr Therapeutics Ag earnings for the quarter were $89.35 million. In the same quarter last year, Crispr Therapeutics Ag's earnings per share (EPS) was -$1.40.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.

What was CRSP's earnings growth in the past year?

As of Q1 2024, Crispr Therapeutics Ag's earnings has grown year over year. Crispr Therapeutics Ag's earnings in the past year totalled -$153.61 million.

What is CRSP's earnings date?

Crispr Therapeutics Ag's earnings date is Invalid Date. Add CRSP to your watchlist to be reminded of CRSP's next earnings announcement.

What was CRSP's revenue last quarter?

On Invalid Date, Crispr Therapeutics Ag (NASDAQ: CRSP) reported Q4 2023 revenue of $201.21 million up 3,353,333.33% year over year. In the same quarter last year, Crispr Therapeutics Ag's revenue was $6.00 thousand.

What was CRSP's revenue growth in the past year?

As of Q1 2024, Crispr Therapeutics Ag's revenue has grown 30,885.48% year over year. This is 30,716.18 percentage points higher than the US Biotechnology industry revenue growth rate of 169.3%. Crispr Therapeutics Ag's revenue in the past year totalled $371.21 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.